Smith Asset Management Group »

Amneal Pharmaceuticals shares owned by Smith Asset Management Group

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Smith Asset Management Group from 13F filings

Historical chart of Smith Asset Management Group investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Smith Asset Management Group

Quarter filed Position value Share count Share price at filing
2021-06-30 $21k 4.2k 5.01
2021-03-31 $20k 3.0k 6.69
2020-12-31 $332k 73k 4.57
2020-09-30 $674k 174k 3.88
2020-06-30 $827k 174k 4.76
2018-09-30 $2.5M 111k 22.19

More positions owned by Smith Asset Management Group

Apple Common Stock - Long (AAPL)
Microsoft Corp Common Stock - Long (MSFT)
Amazon.com Common Stock - Long (AMZN)
Facebook Common Stock - Long (META)
Alphabet Common Stock - Long (GOOGL)
Nvidia Corp Common Stock - Long (NVDA)
Fortinet Common Stock - Long (FTNT)
Adobe Common Stock - Long (ADBE)
United Parcel Service Common Stock - Long (UPS)
Jpmorgan Chase & Co Common Stock - Long (JPM)
Parker-Hannifin Corp Common Stock - Long (PH)
Target Corp Common Stock - Long (TGT)
Capital One Financial Corp Common Stock - Long (COF)
Paypal Holdings Common Stock - Long (PYPL)
Epam Systems Common Stock - Long (EPAM)

View all positions for Smith Asset Management Group

Top funds holding Amneal Pharmaceuticals

UBS Group
Vanguard Group
BlackRock
Tpg Gp A
Rubric Capital Management
Citadel Advisors
Dimensional Fund Advisors
Neuberger Berman Group
Geode Capital Management
State Street Corporation
Nuveen Asset Management
Nantahala Capital Management
BlackBarn Capital Partners
Invesco
Arrowstreet Capital, Limited Partnership

View all funds holding Amneal Pharmaceuticals